OrthoSpin
Smart Robotic External Fixation System
Company Overview
Snapshot
Founded in December 2014 by Yoni Epstein, OrthoSpin operated with 1–10 employees. The company raised $8 million across 3 funding rounds from 2 investors, including Johnson & Johnson Innovation. OrthoSpin was acquired by DePuy Synthes in November 2021.
Business overview
OrthoSpin developed smart external fixation systems designed to enhance orthopedic treatment by providing real-time physician follow-up and reducing patient compliance dependency. Its core technology involved a robotic strut and control box integrated into a circular hexapod fixation frame, which automatically adjusted according to prescribed treatment regimens. The company served the healthcare industry, specifically targeting providers within the orthopedics and digital therapeutics sectors with its digital healthcare solutions.
Strategic signal
OrthoSpin's acquisition by DePuy Synthes in November 2021 signals a successful exit for its investors and validates the market's interest in robotic and digitally-enabled orthopedic solutions. This event highlights the increasing demand for automated, precise, and patient-independent medical devices in the orthopedic sector, indicating a strategic move by a major player to integrate advanced technology into its product offerings.
Log in to access full profile ›Company Intelligence Q&A
- When was OrthoSpin acquired?
- OrthoSpin was acquired by DePuy Synthes in November 2021.
- Which investors participated in OrthoSpin's Series B financing round?
- In March 2020, OrthoSpin secured Series B financing from Johnson & Johnson Innovation and The Trendlines Group.
- When did OrthoSpin receive FDA clearance for its G2 system?
- OrthoSpin received FDA regulatory clearance for its second-generation robotic, digitally enabled external fixation system (G2 system) in January 2021.
- What was a key feature of OrthoSpin's technology?
- OrthoSpin's system allowed physicians to chart patient progress and modify treatment schedules via proprietary software, ensuring the prescribed course of treatment was followed automatically without direct patient intervention.